María G. Kuba

2.7k total citations
20 papers, 1.5k citations indexed

About

María G. Kuba is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, María G. Kuba has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in María G. Kuba's work include HER2/EGFR in Cancer Research (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Advanced Breast Cancer Therapies (5 papers). María G. Kuba is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Advanced Breast Cancer Therapies (5 papers). María G. Kuba collaborates with scholars based in United States, United Kingdom and Australia. María G. Kuba's co-authors include Carlos L. Arteaga, Violeta Sánchez, Justin M. Balko, Anindita Chakrabarty, Cammie Rinehart, Todd W. Miller, Gordon B. Mills, Ana M. González-Angulo, Emily M. Fox and Melinda E. Sanders and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

María G. Kuba

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
María G. Kuba United States	14	897	773	445	370	184	20	1.5k
Heidi Savage United States	12	801 0.9×	731 0.9×	389 0.9×	489 1.3×	138 0.8×	23	1.4k
Edward Rosfjord United States	19	938 1.0×	1.0k 1.3×	383 0.9×	271 0.7×	138 0.8×	39	1.9k
Neil A. O’Brien United States	23	821 0.9×	1.0k 1.3×	455 1.0×	265 0.7×	191 1.0×	55	1.6k
Antonio Marchetti Italy	23	929 1.0×	878 1.1×	715 1.6×	594 1.6×	102 0.6×	39	1.8k
Iwan Beuvink Switzerland	11	1.1k 1.3×	840 1.1×	204 0.5×	304 0.8×	86 0.5×	13	1.7k
Dhivya R. Sudhan United States	13	639 0.7×	505 0.7×	341 0.8×	416 1.1×	71 0.4×	28	1.2k
A. W. Tolcher United States	19	821 0.9×	583 0.8×	310 0.7×	201 0.5×	72 0.4×	107	1.3k
José Jiménez Spain	14	893 1.0×	992 1.3×	287 0.6×	268 0.7×	114 0.6×	39	1.6k
Katherine E. Hutchinson United States	19	972 1.1×	920 1.2×	536 1.2×	595 1.6×	180 1.0×	48	1.8k
Careen K. Tang United States	21	980 1.1×	800 1.0×	210 0.5×	180 0.5×	116 0.6×	27	1.6k

Countries citing papers authored by María G. Kuba

Since Specialization

Citations

This map shows the geographic impact of María G. Kuba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María G. Kuba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María G. Kuba more than expected).

Fields of papers citing papers by María G. Kuba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María G. Kuba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María G. Kuba. The network helps show where María G. Kuba may publish in the future.

Co-authorship network of co-authors of María G. Kuba

This figure shows the co-authorship network connecting the top 25 collaborators of María G. Kuba. A scholar is included among the top collaborators of María G. Kuba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María G. Kuba. María G. Kuba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cook, Rebecca S., Adam D. Pfefferle, Christian D. Young, et al.. (2020). Conditional Loss of ErbB3 Delays Mammary Gland Hyperplasia Induced by Mutant PIK3CA without Affecting Mammary Tumor Latency, Gene Expression, or Signaling. UNC Libraries.

Kuba, María G., Cindy L. Vnencak‐Jones, Julia A. Bridge, et al.. (2016). Primary Carcinoid Tumor of the Renal Pelvis Arising From Intestinal Metaplasia: An Unusual Histogenetic Pathway?. Applied immunohistochemistry & molecular morphology. 25(7). e49–e57. 3 indexed citations

Iqbal, Junaid, Kevin R. Dufendach, John C. Wellons, et al.. (2016). Lethal neonatal meningoencephalitis caused by multi-drug resistant, highly virulentEscherichia coli. Infectious Diseases. 48(6). 461–466. 18 indexed citations

Hutchinson, Katherine E., Douglas B. Johnson, Violeta Sánchez, et al.. (2015). ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma. Oncotarget. 6(26). 22348–22360. 7 indexed citations

Mayer, Ingrid A., Vandana G. Abramson, Steven J. Isakoff, et al.. (2014). Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Journal of Clinical Oncology. 32(12). 1202–1209. 142 indexed citations

Schwarz, Luis J., Emily M. Fox, Justin M. Balko, et al.. (2014). LYN-activating mutations mediate antiestrogen resistance in estrogen receptor–positive breast cancer. Journal of Clinical Investigation. 124(12). 5490–5502. 31 indexed citations

Dennison, Jennifer B., Jennifer R. Molina, Shreya Mitra, et al.. (2013). Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Cancer Research. 19(13). 3703–3713. 93 indexed citations

Young, Christian D., Adam D. Pfefferle, Philip Owens, et al.. (2013). Conditional Loss of ErbB3 Delays Mammary Gland Hyperplasia Induced by Mutant PIK3CA without Affecting Mammary Tumor Latency, Gene Expression, or Signaling. Cancer Research. 73(13). 4075–4085. 20 indexed citations

Sanders, Melinda E., María G. Kuba, Jaime Farley, et al.. (2013). Clinical and pathologic characteristics of patients with PI3K-mutant breast cancers.. Journal of Clinical Oncology. 31(26_suppl). 8–8. 2 indexed citations

10.

Hanker, Ariella B., Adam D. Pfefferle, Justin M. Balko, et al.. (2013). Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies. Proceedings of the National Academy of Sciences. 110(35). 14372–14377. 147 indexed citations

11.

Fox, Emily M., María G. Kuba, Todd W. Miller, Barry R. Davies, & Carlos L. Arteaga. (2013). Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation. Breast Cancer Research. 15(4). R55–R55. 71 indexed citations

12.

Morrison, Meghan M., Katherine E. Hutchinson, Michelle M. Williams, et al.. (2013). ErbB3 downregulation enhances luminal breast tumor response to antiestrogens. Journal of Clinical Investigation. 123(10). 4329–4343. 45 indexed citations

13.

Balko, Justin M., Rebecca S. Cook, David Vaught, et al.. (2012). Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nature Medicine. 18(7). 1052–1059. 197 indexed citations

14.

Hanker, Ariella B., María G. Kuba, Violeta Sánchez, et al.. (2012). Abstract 4875: Human HER2 and PI3K H1047R cooperate to promote mammary tumorigenesis in vivo. Cancer Research. 72(8_Supplement). 4875–4875. 9 indexed citations

15.

Balko, Justin M., Melinda E. Sanders, María G. Kuba, et al.. (2012). A gene expression signature of MEK pathway activation to predict survival in triple-negative breast cancer.. Journal of Clinical Oncology. 30(15_suppl). 1024–1024. 3 indexed citations

16.

Mayer, Ingrid A., Vandana G. Abramson, Justin M. Balko, et al.. (2012). SU2C phase Ib study of pan-PI3K inhibitor BKM120 with letrozole in ER+/HER2- metastatic breast cancer (MBC).. Journal of Clinical Oncology. 30(15_suppl). 510–510. 19 indexed citations

17.

Balko, Justin M., Ingrid A. Mayer, Melinda E. Sanders, et al.. (2012). Discordant Cellular Response to Presurgical Letrozole in Bilateral Synchronous ER+ Breast Cancers with aKRASMutation orFGFR1Gene Amplification. Molecular Cancer Therapeutics. 11(10). 2301–2305. 16 indexed citations

18.

Chakrabarty, Anindita, Violeta Sánchez, María G. Kuba, Cammie Rinehart, & Carlos L. Arteaga. (2011). Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors. Proceedings of the National Academy of Sciences. 109(8). 2718–2723. 276 indexed citations

19.

Fox, Emily M., Todd W. Miller, Justin M. Balko, et al.. (2011). A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer. Cancer Research. 71(21). 6773–6784. 131 indexed citations

20.

Miller, Todd W., Justin M. Balko, Emily M. Fox, et al.. (2011). ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer. Cancer Discovery. 1(4). 338–351. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact